HomeNRX • CVE
add
Nurexone Biologic Inc
Previous close
$0.65
Day range
$0.64 - $0.65
Year range
$0.19 - $1.19
Market cap
42.64M CAD
Avg Volume
81.34K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 407.00K | -10.75% |
Net income | -737.00K | 27.32% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -713.00K | 15.12% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 541.00K | -78.03% |
Total assets | 2.17M | -22.33% |
Total liabilities | 1.98M | 183.81% |
Total equity | 189.00K | — |
Shares outstanding | 65.81M | — |
Price to book | ∞ | — |
Return on assets | -99.97% | — |
Return on capital | -169.51% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -737.00K | 27.32% |
Cash from operations | -633.00K | 19.77% |
Cash from investing | -44.00K | -833.33% |
Cash from financing | 90.00K | -8.16% |
Net change in cash | -602.00K | 12.50% |
Free cash flow | -1.56M | -87.33% |
About
Founded
2011
Website
Employees
12